Web Analytics




Home Tags Posts tagged with "YS Biopharma"

Tag: YS Biopharma

Deal digest

China’s YishengBio eyes US capital markets via SPAC route

Yisheng Biopharma has abandoned its Hong Kong IPO and turned instead to the Nasdaq via the SPAC route in a deal that is expected to be sealed by the first quarter of 2023

0

LATEST ON LAW.ASIA

MOST READ ON LAW.ASIA

Correspondents

Biosimilar Patent Litigation India

Trends in biologic patent litigation

By Swati Sharma and Gitika Suri, Cyril Amarchand Mangaldas
konektadong-pinoy-act-expanding-access-redefining-competition

Konektadong Pinoy Act: Expanding access, redefining competition

By Jayson P Baltazar, ACCRALAW
NSDL Share Transfer Rulesvideo

Consent required for electronic share transfer in private companies

By Ayush Jain and Priankita Das, Bharucha & Partners
Earth to orbit- Planning India playbook

Earth to orbit: Planning India’s playbook

By Paridhi Adani, Cyril Amarchand Mangaldas
Follow Law.asia
Law firms Awards Events Legal jobs • Post a job
About us Archive Subscribe Contact us
Please send any press releases, deal announcements, details of new hires, newsletters and any other news items to: news@law.asia
© Copyright 2026 Law.asia Limited. All rights reserved.

Follow us on LinkedIn

Follow now